{"id":"standard-covid-19-care","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia (corticosteroid-related)"},{"rate":null,"effect":"Thrombocytopenia (anticoagulation-related)"},{"rate":null,"effect":"Secondary infections"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":{"chemblId":"CHEMBL5314794","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Standard COVID-19 care is a multimodal treatment approach rather than a single drug, typically including oxygen supplementation for hypoxemia, antiviral agents (such as remdesivir) to inhibit viral replication, corticosteroids (such as dexamethasone) to reduce excessive inflammation, and anticoagulation to prevent thrombotic complications. The approach is tailored to disease severity and patient factors.","oneSentence":"Standard COVID-19 care encompasses supportive and therapeutic interventions including oxygen therapy, antivirals, corticosteroids, and anticoagulation to manage viral infection and prevent severe complications.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:36:09.196Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 (mild to severe)"}]},"trialDetails":[{"nctId":"NCT04305457","phase":"PHASE2","title":"Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2020-03-21","conditions":"Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome","enrollment":62},{"nctId":"NCT03684980","phase":"EARLY_PHASE1","title":"LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-11-14","conditions":"Central Nervous System Lymphoma","enrollment":58},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT07469670","phase":"","title":"Nasal Swab Objective and Statistical Evaluation (NOSE Study)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-04-05","conditions":"SARS Coronavirus 2 RT-PCR Testing","enrollment":1179},{"nctId":"NCT04055948","phase":"NA","title":"Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2019-12-17","conditions":"Cancer","enrollment":484},{"nctId":"NCT07450209","phase":"PHASE2","title":"COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Missouri, Kansas City","startDate":"2024-05-15","conditions":"COVID-19 Testing Behaviors","enrollment":900},{"nctId":"NCT04382131","phase":"NA","title":"Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)","status":"TERMINATED","sponsor":"University of Edinburgh","startDate":"2020-06-23","conditions":"Upper Respiratory Tract Infections, Virus, COVID","enrollment":16},{"nctId":"NCT05123755","phase":"PHASE2","title":"Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.","status":"RECRUITING","sponsor":"Vasomune Therapeutics, Inc.","startDate":"2021-12-20","conditions":"Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia","enrollment":120},{"nctId":"NCT03830320","phase":"PHASE1","title":"Positron Emission Tomography (PET) Imaging of Thrombosis","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2016-04-01","conditions":"Atrial Fibrillation, COVID-19, Cancer","enrollment":165},{"nctId":"NCT05254990","phase":"PHASE3","title":"Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-04-27","conditions":"Infectious Pneumonia, Severe COVID-19","enrollment":414},{"nctId":"NCT04565509","phase":"NA","title":"Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-11-20","conditions":"Covid19, Intellectual Disability, Developmental Disability","enrollment":1143},{"nctId":"NCT06343545","phase":"NA","title":"The Tele-Rehab MV Cluster Stepped-Wedge Randomized Clinical Trial","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2024-06-10","conditions":"Acute Respiratory Failure","enrollment":1916},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT06505993","phase":"NA","title":"Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia","status":"SUSPENDED","sponsor":"Marc Kiviniemi","startDate":"2026-09","conditions":"COVID-19, Vaccine Hesitancy","enrollment":2250},{"nctId":"NCT05777720","phase":"NA","title":"Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes","status":"COMPLETED","sponsor":"Stanford University","startDate":"2023-01-30","conditions":"Covid19","enrollment":214},{"nctId":"NCT07406217","phase":"PHASE2","title":"OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients","status":"RECRUITING","sponsor":"Calmy Alexandra","startDate":"2023-04-27","conditions":"COVID-19, Immunodeficiency","enrollment":256},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT04415060","phase":"PHASE3","title":"SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-06-15","conditions":"Covid19, Hypoxic Respiratory Failure","enrollment":800},{"nctId":"NCT07397130","phase":"NA","title":"Inspiratory Muscle Pressure and Diaphragmatic Strength in Women With Long COVID-19: A Pressure Biofeedback-Guided Training Study","status":"COMPLETED","sponsor":"RSUP Persahabatan","startDate":"2024-07-01","conditions":"Long COVID-19 Syndrome, Post COVID Syndrome Long Covid, Post COVID-19 Syndrome","enrollment":80},{"nctId":"NCT07374991","phase":"NA","title":"Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2020-11-01","conditions":"COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)","enrollment":59},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT07157007","phase":"PHASE2","title":"Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19","status":"RECRUITING","sponsor":"Traws Pharma, Inc.","startDate":"2025-09-16","conditions":"COVID - 19","enrollment":90},{"nctId":"NCT07352254","phase":"NA","title":"OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)","status":"RECRUITING","sponsor":"Hannover Medical School","startDate":"2026-01","conditions":"ME/CFS","enrollment":100},{"nctId":"NCT04910269","phase":"PHASE3","title":"Outpatient Treatment With Anti-Coronavirus Immunoglobulin","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-06","conditions":"COVID, SARS-CoV2 Infection, Covid19","enrollment":820},{"nctId":"NCT03963622","phase":"NA","title":"Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)","status":"RECRUITING","sponsor":"Unity Health Toronto","startDate":"2020-11-23","conditions":"ARDS","enrollment":740},{"nctId":"NCT04746183","phase":"PHASE1, PHASE2","title":"AGILE (Early Phase Platform Trial for COVID-19)","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2020-07-03","conditions":"Covid19","enrollment":600},{"nctId":"NCT04379518","phase":"PHASE1, PHASE2","title":"Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2020-11-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed","enrollment":4},{"nctId":"NCT05091957","phase":"NA","title":"Connecting Families","status":"RECRUITING","sponsor":"Queen's University","startDate":"2022-05-17","conditions":"Poverty, Primary Care, Intervention","enrollment":80},{"nctId":"NCT06202521","phase":"PHASE2","title":"CX-4945 in Viral Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Senhwa Biosciences, Inc.","startDate":"2024-03-20","conditions":"Community-acquired Pneumonia, SARS-CoV-2 -Associated Pneumonia, Influenza With Pneumonia","enrollment":45},{"nctId":"NCT05077254","phase":"PHASE2","title":"COVID Protection After Transplant-Immunosuppression Reduction","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-12-06","conditions":"Kidney Transplant Recipients, Liver Transplant Recipients","enrollment":48},{"nctId":"NCT06189066","phase":"NA","title":"Long COVID Ultrasound Trial","status":"COMPLETED","sponsor":"SecondWave Systems Inc.","startDate":"2024-01-03","conditions":"Long Covid","enrollment":15},{"nctId":"NCT04452097","phase":"PHASE1, PHASE2","title":"Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS","status":"WITHDRAWN","sponsor":"Baylx Inc.","startDate":"2026-06-01","conditions":"COVID-19, ARDS, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT05228275","phase":"","title":"Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2022-04-08","conditions":"COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":549},{"nctId":"NCT07280572","phase":"PHASE3","title":"RECLAIM Adaptive Platform Trial for PCC Treatments","status":"ENROLLING_BY_INVITATION","sponsor":"Janneke van de Wijgert","startDate":"2025-02-17","conditions":"Post COVID Condition","enrollment":1250},{"nctId":"NCT04369807","phase":"","title":"Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection","status":"COMPLETED","sponsor":"Perspectum","startDate":"2020-04-21","conditions":"COVID-19","enrollment":693},{"nctId":"NCT04780659","phase":"PHASE4","title":"COVID-19 Vaccination of Immunodeficient Persons (COVAXID)","status":"COMPLETED","sponsor":"Karolinska University Hospital","startDate":"2021-02-23","conditions":"Covid19","enrollment":539},{"nctId":"NCT06992401","phase":"","title":"Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism","status":"NOT_YET_RECRUITING","sponsor":"Tamara C Tamas","startDate":"2026-08-01","conditions":"Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID, Long COVID Fatigue","enrollment":50},{"nctId":"NCT07110714","phase":"NA","title":"Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients","status":"RECRUITING","sponsor":"Eggensberger OHG","startDate":"2025-12-01","conditions":"Post COVID-19 Condition, Post COVID-19 Condition (PCC), Post COVID-19","enrollment":30},{"nctId":"NCT04393038","phase":"PHASE2, PHASE3","title":"ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19","status":"TERMINATED","sponsor":"Abivax S.A.","startDate":"2020-07-01","conditions":"COVID-19","enrollment":509},{"nctId":"NCT05852873","phase":"PHASE3","title":"PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2023-05-12","conditions":"Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19","enrollment":2000},{"nctId":"NCT04469491","phase":"PHASE2","title":"Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2020-09-20","conditions":"COVID-19, INTERFERON, NEBULIZATION","enrollment":74},{"nctId":"NCT04581954","phase":"PHASE1, PHASE2","title":"Inflammatory Signal Inhibitors for COVID-19 (MATIS)","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2020-10-02","conditions":"Coronavirus, Covid19, Pneumonia","enrollment":185},{"nctId":"NCT03998462","phase":"NA","title":"Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-01-01","conditions":"Parkinson's Disease","enrollment":107},{"nctId":"NCT05102656","phase":"NA","title":"Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-06-02","conditions":"COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":107},{"nctId":"NCT04545541","phase":"PHASE2, PHASE3","title":"Nebulised Heparin in Patients With Severe COVID-19","status":"COMPLETED","sponsor":"Australian National University","startDate":"2020-11-01","conditions":"Covid19, Respiratory Failure","enrollment":57},{"nctId":"NCT07221097","phase":"","title":"Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses","status":"RECRUITING","sponsor":"BioFire Defense LLC","startDate":"2025-09-29","conditions":"Coronavirus, Respiratory Infection, COVID","enrollment":1500},{"nctId":"NCT04428008","phase":"PHASE2","title":"Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients","status":"COMPLETED","sponsor":"William B. Ershler, MD","startDate":"2021-01-12","conditions":"COVID-19","enrollment":262},{"nctId":"NCT06579222","phase":"NA","title":"Comorbidity Management in Rheumatic Disease.","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2025-05-01","conditions":"Rheumatoid Arthritis, Comorbidities and Coexisting Conditions","enrollment":199},{"nctId":"NCT06647654","phase":"","title":"Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-08-26","conditions":"Respiratory Syncytial Virus, Respiratory Tract Diseases","enrollment":1},{"nctId":"NCT05113641","phase":"NA","title":"Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)","status":"RECRUITING","sponsor":"Dylan MacKay","startDate":"2023-08-04","conditions":"Chronic Kidney Diseases, Metabolic Acidosis","enrollment":40},{"nctId":"NCT05220163","phase":"NA","title":"Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2022-02-23","conditions":"Tuberculosis, COVID-19, HIV Infections","enrollment":26200},{"nctId":"NCT05552625","phase":"PHASE2, PHASE3","title":"The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19","status":"WITHDRAWN","sponsor":"Helixmith Co., Ltd.","startDate":"2021-05-06","conditions":"COVID-19","enrollment":""},{"nctId":"NCT05074693","phase":"NA","title":"Mobile Health and COVID-19","status":"COMPLETED","sponsor":"University of Houston","startDate":"2021-12-20","conditions":"Anxiety Depression","enrollment":822},{"nctId":"NCT04553705","phase":"PHASE2, PHASE3","title":"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2020-09-20","conditions":"Covid19, Immunodeficiency","enrollment":150},{"nctId":"NCT05228886","phase":"NA","title":"The SINCERE Intervention to Address COVID-19 Health Disparities","status":"RECRUITING","sponsor":"Andrea Wallace","startDate":"2021-09-27","conditions":"COVID-19, Vulnerable Populations, Social Determinants of Health","enrollment":1500},{"nctId":"NCT05866237","phase":"NA","title":"COVID-19 Vaccine Uptake Amongst Underserved Populations in East London","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2023-11-28","conditions":"COVID-19, Influenza, Vaccination Refusal","enrollment":5903},{"nctId":"NCT04345614","phase":"PHASE2","title":"A Study of Auxora in Patients With Severe COVID-19 Pneumonia","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2020-04-08","conditions":"Pneumonia","enrollment":314},{"nctId":"NCT05220397","phase":"PHASE3","title":"Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients","status":"TERMINATED","sponsor":"Mark Stegall","startDate":"2022-04-11","conditions":"Kidney Transplant Recipient","enrollment":468},{"nctId":"NCT06062056","phase":"NA","title":"Motivational Interviewing for Vaccine Uptake in Latinx Adults","status":"TERMINATED","sponsor":"Boston College","startDate":"2023-10-02","conditions":"Vaccine Hesitancy","enrollment":3698},{"nctId":"NCT05543642","phase":"PHASE4","title":"The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2022-10-11","conditions":"Rheumatic Diseases","enrollment":129},{"nctId":"NCT05699538","phase":"NA","title":"Fatigability in Long COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-07-31","conditions":"Long COVID","enrollment":21},{"nctId":"NCT05994261","phase":"NA","title":"Cereset Research Long-Term Healthcare Worker Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-11-06","conditions":"Stress, Anxiety, Autonomic Dysregulation","enrollment":94},{"nctId":"NCT04427280","phase":"","title":"Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2020-05-26","conditions":"Infectious Disease, Cancer, Coronavirus Infection","enrollment":153},{"nctId":"NCT05570630","phase":"NA","title":"VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2022-10-21","conditions":"Immunization; Infection, Pregnancy Related, COVID-19","enrollment":6911},{"nctId":"NCT04482621","phase":"PHASE2","title":"Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial","status":"SUSPENDED","sponsor":"Johns Hopkins University","startDate":"2020-09-14","conditions":"COVID-19","enrollment":33},{"nctId":"NCT06821113","phase":"NA","title":"Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-07-03","conditions":"COVID-19","enrollment":150},{"nctId":"NCT07135622","phase":"NA","title":"Xpert MTB/RIF Ultra Trial","status":"COMPLETED","sponsor":"Nestani Tukvadze","startDate":"2019-05-27","conditions":"Tuberculosis (TB), Pulmonary TB","enrollment":778},{"nctId":"NCT05595837","phase":"","title":"Immune Registry for Organ Transplantation From COVID Positive Donors.","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2022-12-29","conditions":"COVID-19, Organ Transplant","enrollment":20},{"nctId":"NCT04716998","phase":"PHASE1, PHASE2","title":"Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19","status":"COMPLETED","sponsor":"BonusBio Group Ltd","startDate":"2021-01-14","conditions":"Covid19","enrollment":50},{"nctId":"NCT04356833","phase":"PHASE2","title":"Nebulised Rt-PA for ARDS Due to COVID-19","status":"COMPLETED","sponsor":"University College, London","startDate":"2020-04-22","conditions":"COVID","enrollment":35},{"nctId":"NCT04473053","phase":"PHASE1, PHASE2","title":"DEFINE - Evaluating Therapies for COVID-19","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2020-07-03","conditions":"COVID-19","enrollment":71},{"nctId":"NCT06156176","phase":"NA","title":"Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial","status":"RECRUITING","sponsor":"Lawson Research Institute of St. Joseph's","startDate":"2025-04-01","conditions":"Long-COVID, Long COVID-19, Post-COVID-19 Syndrome","enrollment":60},{"nctId":"NCT04467840","phase":"PHASE2, PHASE3","title":"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2020-08-21","conditions":"COVID-19, Lung Infection","enrollment":475},{"nctId":"NCT07090486","phase":"","title":"A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-04-15","conditions":"COVID-19","enrollment":14000},{"nctId":"NCT05893420","phase":"NA","title":"A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgileMD, Inc.","startDate":"2024-12-31","conditions":"Sepsis, Septicemia, Respiratory Failure","enrollment":30000},{"nctId":"NCT04532931","phase":"PHASE2","title":"Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2020-09-03","conditions":"COVID-19","enrollment":192},{"nctId":"NCT06873633","phase":"PHASE2","title":"Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2025-07-16","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT07075939","phase":"","title":"Centralization and Oncologic Outcomes in Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2025-06-27","conditions":"Epithelial Ovarian Cancer, Ovarian Neoplasms, Advanced Ovarian Cancer","enrollment":200},{"nctId":"NCT04878328","phase":"NA","title":"Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2022-04-14","conditions":"Covid19","enrollment":250},{"nctId":"NCT05841810","phase":"NA","title":"Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-08-20","conditions":"COVID-19","enrollment":398},{"nctId":"NCT04912817","phase":"NA","title":"PR-VR At-home Program During and After COVID-19","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2022-09-01","conditions":"Pain, Chronic","enrollment":40},{"nctId":"NCT05459532","phase":"PHASE2, PHASE3","title":"A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2022-08-12","conditions":"COVID-19","enrollment":59},{"nctId":"NCT07029048","phase":"","title":"Oxidative Stress and Cognitive Dysfunction After COVID-19","status":"COMPLETED","sponsor":"Karaganda Medical University","startDate":"2021-03-01","conditions":"COVID 19, Oxydative Stress, Cognitive Impairments","enrollment":45},{"nctId":"NCT04635241","phase":"PHASE2, PHASE3","title":"Inhaled Heparin for Hospitalised COVID-19 Patients","status":"COMPLETED","sponsor":"Australian National University","startDate":"2020-06-01","conditions":"Covid19","enrollment":485},{"nctId":"NCT04324073","phase":"PHASE2, PHASE3","title":"Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-27","conditions":"Corona Virus Infection","enrollment":239},{"nctId":"NCT04331808","phase":"PHASE2","title":"CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-30","conditions":"Corona Virus Infection","enrollment":228},{"nctId":"NCT04341584","phase":"PHASE2","title":"CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-08","conditions":"Corona Virus Infection","enrollment":161},{"nctId":"NCT05022472","phase":"PHASE4","title":"Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California","status":"COMPLETED","sponsor":"Britt Skaathun","startDate":"2021-07-16","conditions":"Vaccine Refusal, Covid19","enrollment":1051},{"nctId":"NCT04479358","phase":"PHASE2","title":"Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2020-09-10","conditions":"COVID-19","enrollment":85},{"nctId":"NCT05321407","phase":"","title":"COVID-19 Vaccine Responses in PIDD Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2021-09-30","conditions":"X-linked Agammaglobulinemia, XLA, Primary Immune Deficiency","enrollment":100},{"nctId":"NCT06997666","phase":"NA","title":"Effect of Prone Position on Oxygen, Blood Gas, and Respiratory Parameters in Intensive Care Patients With COVID-19-induced ARDS","status":"COMPLETED","sponsor":"Medet Korkmaz","startDate":"2021-03-01","conditions":"COVID - 19, ARDS (Acute Respiratory Distress Syndrome)","enrollment":90},{"nctId":"NCT04347226","phase":"PHASE2","title":"Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19","status":"TERMINATED","sponsor":"Columbia University","startDate":"2020-04-16","conditions":"Solid Tumor, Sars-CoV2, Hematological Malignancy","enrollment":43},{"nctId":"NCT04969991","phase":"PHASE2","title":"Study of Varespladib in Patients Hospitalized With Severe COVID-19","status":"TERMINATED","sponsor":"Ophirex, Inc.","startDate":"2021-06-30","conditions":"Coronavirus Disease 2019, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":18},{"nctId":"NCT04979884","phase":"PHASE3","title":"Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-03","conditions":"COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Pulmonary Fibrosis","enrollment":66},{"nctId":"NCT05379504","phase":"NA","title":"Reducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart Technology","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2022-06-01","conditions":"Quality of Life, Disabilities Multiple","enrollment":58},{"nctId":"NCT06964048","phase":"NA","title":"Evaluation of Cold Plasma in Chronic Wound Healing","status":"NOT_YET_RECRUITING","sponsor":"Plasana Medical","startDate":"2025-06","conditions":"Chronic Wounds, Venous Leg Ulcer (VLU), Diabetic Foot Ulcer (DFU)","enrollment":66},{"nctId":"NCT05286242","phase":"","title":"Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2021-02-10","conditions":"Multiple Sclerosis, Autoimmune Blistering Disease, B-Cell Deficiency","enrollment":400},{"nctId":"NCT06146361","phase":"NA","title":"Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-11-03","conditions":"COVID-19","enrollment":359},{"nctId":"NCT04904536","phase":"PHASE3","title":"Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The George Institute","startDate":"2022-03-10","conditions":"Neurocognitive Impairment, Mild","enrollment":190},{"nctId":"NCT04566614","phase":"","title":"Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2020-06-18","conditions":"Neoplasm, Colorectal, Neoplasm of Lung, Neoplasm, Bladder","enrollment":128}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":67,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Standard COVID-19 care","genericName":"Standard COVID-19 care","companyName":"Liaquat University of Medical & Health Sciences","companyId":"liaquat-university-of-medical-health-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard COVID-19 care encompasses supportive and therapeutic interventions including oxygen therapy, antivirals, corticosteroids, and anticoagulation to manage viral infection and prevent severe complications. Used for COVID-19 (mild to severe).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}